EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

End-stage liver failure: filling the treatment gap at the intensive care unit

Robert A F M Chamuleau, Ruurdtje Hoekstra

Journal of Artificial Organs · 2020-06 · 23 (2) · 113-123

DOI: 10.1007/s10047-019-01133-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Artificial Organs, online erschienen am 18.09.2019. Verfasst von Robert A F M Chamuleau und 1 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&M, Academic Medical Center, Meibergdreef 69-71, S1-176…. Hauptthemen laut MEDLINE: Liver, Artificial, Plasma Exchange, Plasmapheresis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

End-stage liver failure is a condition of collapsing liver function with mortality rates up to 80. Liver transplantation is the only lifesaving therapy. There is an unmet need for therapy to extend the waiting time for liver transplantation or regeneration of the native liver. Here we review the state-of-the-art of non-cell based and cell-based artificial liver support systems, cell transplantation and plasma exchange, with the first therapy relying on detoxification, while the others aim to correct also other failing liver functions and/or modulate the immune response. Meta-analyses on the effect of non-cell based systems show contradictory outcomes for different types of albumin purification devices. For bioartificial livers proof of concept has been shown in animals with liver failure. However, large clinical trials with two different systems did not show a survival benefit. Two clinical trials with plasma exchange and one with transplantation of mesenchymal stem cells showed positive outcomes on survival. Detoxification therapies lack adequacy for most patients. Correction of additional liver functions, and also modulation of the immune system hold promise for future therapy of liver failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver, ArtificialPlasma ExchangePlasmapheresisAnimalsCell TransplantationEnd Stage Liver DiseaseHumansIntensive Care Units

Stichwörter der Autor:innen

Acute liver failureAcute on chronic liver failureArtificial liverLiver transplantation

Autor:innen und Institutionen

  • Amsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&M, Academic Medical Center, Meibergdreef 69-71, S1-176, 1105 BK, Amsterdam, The Netherlands. r.a.chamuleau@amc.uva.nl.
  • Amsterdam UMC, University of Amsterdam, Tytgat Institute for Liver and Intestinal Research, AG&M, Academic Medical Center, Meibergdreef 69-71, S1-176, 1105 BK, Amsterdam, The Netherlands.

Zitieren

APA

Chamuleau, R. A. F. M., & Hoekstra, R. (2020). End-stage liver failure: filling the treatment gap at the intensive care unit. Journal of Artificial Organs, 23(2), 113-123. https://doi.org/10.1007/s10047-019-01133-3

Vancouver

Chamuleau RAFM, Hoekstra R. End-stage liver failure: filling the treatment gap at the intensive care unit. Journal of Artificial Organs. 2020;23(2):113-123. doi:10.1007/s10047-019-01133-3

BibTeX
@article{Chamuleau2020,
  author = {Chamuleau, Robert A F M and Hoekstra, Ruurdtje},
  title = {End-stage liver failure: filling the treatment gap at the intensive care unit},
  journal = {Journal of Artificial Organs},
  year = {2020},
  volume = {23},
  number = {2},
  pages = {113--123},
  doi = {10.1007/s10047-019-01133-3}
}
Kostenlos starten →